Tandospirone suppresses impulsive action by possible blockade of the 5-HT1A receptor

Journal of Pharmacological Sciences

Volumn 122, Issue 2, 2013, Pages 84-92

  Ohmura, Yu ^a   Kumamoto, Haruko ^a   Tsutsui Kimura, Iku ^a   Minami, Masabumi ^b   Izumi, Takeshi ^a   Yoshida, Takayuki ^a   Yoshioka, Mitsuhiro ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Anxiolytic; Behavioral inhibition; Impulsive behavior; Inhibitory control

Indexed keywords

ANXIOLYTIC AGENT; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; TANDOSPIRONE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; IMPULSIVENESS; MALE; MENTAL DISEASE; NONHUMAN; RAT; RECEPTOR BLOCKING; RESPONSE TIME; TASK PERFORMANCE;

EID: 84880800830     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.12264FP     Document Type: Article

References (41)

1. Ohmura Y, Takahashi T, Kitamura N. Discounting delayed and probabilistic monetary gains and losses by smokers of cigarettes. Psychopharmacology (Berl). 2005;182:508-515.
2. Diergaarde L, Schoffelmeer AN, De Vries TJ. Pharmacological manipulation of memory reconsolidation: towards a novel treatment of pathogenic memories. Eur J Pharmacol. 2008;585: 453-457.
3. Babinski LM, Hartsough CS, Lambert NM. Childhood conduct problems, hyperactivity-impulsivity, and inattention as predictors of adult criminal activity. J Child Psychol Psychiatry. 1999;40:347-355.
4. Corruble E, Hatem N, Damy C, Falissard B, Guelfi JD, Reynaud M, et al. Defense styles, impulsivity and suicide attempts in major depression. Psychopathology. 2003;36:279-284.
5. Swann AC, Dougherty DM, Pazzaglia PJ, Pham M, Steinberg JL, Moeller FG. Increased impulsivity associated with severity of suicide attempt history in patients with bipolar disorder. Am J Psychiatry. 2005;162:1680-1687.
6. Losier BJ, McGrath PJ, Klein RM. Error patterns on the continuous performance test in non-medicated and medicated samples of children with and without ADHD: a meta-analytic review. J Child Psychol Psychiatry. 1996;37:971-987.
7. Barr RS, Culhane MA, Jubelt LE, Mufti RS, Dyer MA, Weiss AP, et al. The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. Neuropsychopharmacology. 2008;33:480-490.
8. Swann AC, Dougherty DM, Pazzaglia PJ, Pham M, Moeller FG. Impulsivity: a link between bipolar disorder and substance abuse. Bipolar Disord. 2004;6:204-212.
9. Strakowski SM, Fleck DE, DelBello MP, Adler CM, Shear PK, McElroy SL, et al. Characterizing impulsivity in mania. Bipolar Disord. 2009;11:41-51.
10. Dom G, De Wilde B, Hulstijn W, van den Brink W, Sabbe B. Behavioural aspects of impulsivity in alcoholics with and without a cluster-B personality disorder. Alcohol Alcohol. 2006;41: 412-420.
11. Schweighofer N, Bertin M, Shishida K, Okamoto Y, Tanaka SC, Yamawaki S, et al. Low-serotonin levels increase delayed reward discounting in humans. J Neurosci. 2008;28:4528-4532.
12. Harrison AA, Everitt BJ, Robbins TW. Doubly dissociable effects of median- and dorsal-raphe lesions on the performance of the five-choice serial reaction time test of attention in rats. Behav Brain Res. 1997;89:135-149.
13. Harrison AA, Everitt BJ, Robbins TW. Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms. Psychopharmacology (Berl). 1997;133:329-342.
14. Carli M, Samanin R. The 5-HT(1A) receptor agonist 8-OH-DPAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT(1A) receptors. Psychophar-macology (Berl). 2000;149:259-268.
15. Winstanley CA, Chudasama Y, Dalley JW, Theobald DE, Glennon JC, Robbins TW. Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats. Psychophar-macology (Berl). 2003;167:304-314.
16. Tsutsui-Kimura I, Ohmura Y, Izumi T, Yamaguchi T, Yoshida T, Yoshioka M. The effects of serotonin and/or noradrenaline reuptake inhibitors on impulsive-like action assessed by the three-choice serial reaction time task: a simple and valid model of impulsive action using rats. Behav Pharmacol. 2009;20: 474-483.
17. Tsutsui-Kimura I, Ohmura Y, Izumi T, Yamaguchi T, Yoshida T, Yoshioka M. Endogenous acetylcholine modulates impulsive action via alpha4beta2 nicotinic acetylcholine receptors in rats. Eur J Pharmacol. 2010;641:148-153.
18. Tsutsui-Kimura I, Ohmura Y, Izumi T, Yamaguchi T, Yoshida T, Yoshioka M. Nicotine provokes impulsive-like action by stimulating alpha4beta2 nicotinic acetylcholine receptors in the infralimbic, but not in the prelimbic cortex. Psychopharmacology (Berl). 2010;209:351-359.
19. Carli M, Robbins TW, Evenden JL, Everitt BJ. Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res. 1983;9:361-380.
20. Robbins TW. The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharma-cology (Berl). 2002;163:362-380.
21. Ohmura Y, Yamaguchi T, Futami Y, Togashi H, Izumi T, Matsumoto M, et al. Corticotropin releasing factor enhances attentional function as assessed by the five-choice serial reaction time task in rats. Behav Brain Res. 2009;198:429-433.
22. Matsumoto M, Togashi H, Konno K, Koseki H, Hirata R, Izumi T, et al. Early postnatal stress alters the extinction of context-dependent conditioned fear in adult rats. Pharmacol Biochem Behav. 2008;89:247-252.
23. Koseki H, Matsumoto M, Togashi H, Miura Y, Fukushima K, Yoshioka M. Alteration of synaptic transmission in the hippo-campal-mPFC pathway during extinction trials of context-dependent fear memory in juvenile rat stress models. Synapse. 2009;63:805-813.
24. Fernandez-Perez S, Pache DM, Sewell RD. Co-administration of fluoxetine and WAY100635 improves short-term memory function. Eur J Pharmacol. 2005;522:78-83.
25. Manuel-Apolinar L, Meneses A. 8-OH-DPAT facilitated memory consolidation and increased hippocampal and cortical cAMP production. Behav Brain Res. 2004;148:179-184.
26. Sumiyoshi T, Matsui M, Yamashita I, Nohara S, Kurachi M, Uehara T, et al. The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia. Biol Psychiatry. 2001;49:861-868.
27. Assie MB, Mnie-Filali O, Ravailhe V, Benas C, Marien M, Betry C, et al. F15063, a potential antipsychotic with dopamine D2/D3 receptor antagonist, 5-HT1A receptor agonist and dopamine D4 receptor partial agonist properties: influence on neuronal firing and neurotransmitter release. Eur J Pharmacol. 2009;607:74-83.
28. Villalobos-Molina R, Lopez-Guerrero JJ, Gallardo-Ortiz IA, Ibarra M. Evidence that the hypotensive effect of WAY 100635, a 5-HT1A receptor antagonist, is related to vascular alpha 1-adrenoceptor blockade in the adult rat. Auton Autacoid Pharmacol. 2002;22:171-176.
29. Puumala T, Riekkinen P Sr, Sirvio J. Modulation of vigilance and behavioral activation by alpha-1 adrenoceptors in the rat. Pharmacol Biochem Behav. 1997;56:705-712.
30. Hamik A, Oksenberg D, Fischette C, Peroutka SJ. Analysis of tandospirone (SM-3997) interactions with neurotransmitter receptor binding sites. Biol Psychiatry. 1990;28:99-109.
31. Miller LG, Thompson ML, Byrnes JJ, Greenblatt DJ, Shemer A. Kinetics, brain uptake, and receptor binding of tandospirone and its metabolite 1-(2-pyrimidinyl)-piperazine. J Clin Psychophar-macol. 1992;12:341-345.
32. Blier P, Curet O, Chaput Y, de Montigny C. Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine-II. Effects of acute administration of 1-PP and long-term administration of tandospi-rone on noradrenergic neurotransmission. Neuropharmacology. 1991;30:691-701.
33. Puumala T, Bjorklund M, Ruotsalainen S, Riekkinen M, Jakala P, Haapalinna A, et al. Lack of relationship between thalamic oscillations and attention in rats: differential modulation by an alpha-2 antagonist. Brain Res Bull. 1997;43:163-171.
34. Miyazaki KW, Miyazaki K, Doya K. Activation of the central serotonergic system in response to delayed but not omitted rewards. Eur J Neurosci. 2011;33:153-160.
35. Miyazaki K, Miyazaki KW, Doya K. Activation of dorsal raphe serotonin neurons underlies waiting for delayed rewards. J Neurosci. 2011;31:469-479.
36. Sharp T, Boothman L, Raley J, Queree P. Important messages in the "post": recent discoveries in 5-HT neurone feedback control. Trends Pharmacol Sci. 2007;28:629-636.
37. Dawson LA, Nguyen HQ. Effects of 5-HT1A receptor antagonists on fluoxetine-induced changes in extracellular serotonin concentrations in rat frontal cortex. Eur J Pharmacol. 1998;345: 41-46.
38. Sharp T, Umbers V, Gartside SE. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo. Br J Pharmacol. 1997;121:941-946.
39. Baarendse PJ, Vanderschuren LJ. Dissociable effects of mono-amine reuptake inhibitors on distinct forms of impulsive behavior in rats. Psychopharmacology (Berl). 2012;219:313-326.
40. Pompeiano M, Palacios JM, Mengod G. Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding. J Neurosci. 1992;12: 440-453.
41. Feighner JP, Boyer WF. Serotonin-1A anxiolytics: an overview. Psychopathology. 1989;22 Suppl 1:21-26.